PMEF
PDSB icon

Point72 Middle East FZE’s PDS Biotechnology PDSB Stock Holding History

Point72 Middle East FZE’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,766
Closed -$23.2K – 1950
2023
Q1 		$23.2K Buy
+3,766
New +$30.8K ﹤0.01% 1405

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Point72 Middle East FZE's PDSB Position: Q2 2023 in Review

Point72 Middle East FZE sold out of PDS Biotechnology (PDSB) in Q2 2023, closing a stake of 3,766 shares — an estimated $23.2K sold.

Point72 Middle East FZE first reported a position in PDSB in Q1 2023 and held it in 1 quarter. The position peaked at $23.2K in Q1 2023. 80 funds tracked by Wall St. Rank hold PDSB as of Q2 2023.

  • Point72 Middle East FZE reported no remaining PDS Biotechnology position as of Q2 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 3,766 PDS Biotechnology shares in Q2 2023, an estimated $23.2K.
  • Point72 Middle East FZE first reported a position in PDS Biotechnology in Q1 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's PDS Biotechnology position peaked at $23.2K in Q1 2023.
  • 80 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.